Restructuring Actions (Tables)

3 Months Ended

Mar. 31, 2024

Restructuring and Related Activities [Abstract]

Schedule of restructuring and related costs

The related restructuring charges for periods presented were recorded in the income (loss) statement as follows:

	Three months ended March 31,
(Millions)	2024		2023
Cost of sales	$	2	$	16
Selling, general and administrative expenses	92		32
Research, development and related expenses	10		4
Total operating income impact	$	104	$	52

The business segment operating income (loss) impact of these restructuring charges is summarized as follows:

	Three months ended March 31,
	2024						2023
(Millions)	Employee Related		Asset-Related and Other		Total		Employee Related
Safety and Industrial	$	26	$	20	$	46	$	10
Transportation and Electronics	9		15		24		12
Health Care	7		14		21		2
Consumer	5		8		13		3
Corporate and unallocated	—		—		—		25
Total operating expense	$	47	$	57	$	104	$	52

Schedule of restructuring reserve by type of cost

Restructuring actions, including cash and non-cash impacts, follow:

(Millions)	Employee-Related		Asset-Related and Other		Total
Accrued restructuring action balance as of December 31, 2023	$	99	$	—	$	99
Incremental expense incurred in the first quarter of 2024	47		57		104
Non-cash changes	—		(57)		(57)
Adjustments	11		—		11
Cash payments	(53)		—		(53)
Accrued restructuring action balance as of March 31, 2024	$	104	$	—	$	104

The remaining period of activities related to these approved and committed actions aligns with 3M's PFAS exit timeframe.

(Millions)	Employee-Related
Accrued restructuring action balance as of December 31, 2023	$	60
Incremental expense incurred in the first quarter of 2024	4
Cash payments	(13)
Accrued restructuring action balance as of March 31, 2024	$	51